Skip to main content

Table 1 Patient baseline characteristics

From: The survival effect of ovary preservation in early stage endometrial cancer: a single institution retrospective analysis

Variables Total Ovary Preserved Ovary Removed  
N = 539 N = 70 N = 469 P-value
FIGO Stage
 IA 390 (72.36) 60 (85.71) 330 (70.36) 0.0264
 IB 126 (23.38) 8 (11.43) 118 (25.16)  
 II 23 (4.27) 2 (2.86) 21 (4.48)  
FIGO grade
 1 293 (54.36) 41 (58.57) 252 (53.73) 0.289
 2 141 (26.16) 21 (30) 120 (25.59)  
 3 52 (9.65) 5 (7.14) 47 (10.02)  
 Etc. 53 (9.83) 3 (4.29) 50 (10.66)  
Histology
 Endometrioid 461 (85.53) 66 (94.29) 395 (84.22) 0.2329
 Serous 31 (5.75) 2 (2.86) 29 (6.18)  
 CCC 20 (3.71) 1 (1.43) 19 (4.05)  
 Mucinous/mixed/Undifferentiated/NE/etc. 27 (5.01) 1 (1.43) 26 (5.54)  
Age (year)
 mean ± SD 52.68 ± 10.42 40.94 ± 9.56 54.43 ± 9.36 <.0001
 < 30 11 (2.04) 8 (11.43) 3 (0.64) <.0001
 31 ~ 35 19 (3.53) 13 (18.57) 6 (1.28)  
 36 ~ 40 39 (7.24) 21 (30) 18 (3.84)  
 40 ~ 45 51 (9.46) 11 (15.71) 40 (8.53)  
 45> 419 (77.74) 17 (24.29) 402 (85.71)  
Approach
 Laparoscopy 395 (73.28) 60 (85.71) 335 (71.43) 0.0366
 Laparotomy 138 (25.6) 10 (14.29) 128 (27.29)  
 Etc. 6 (1.11) 0 (0) 6 (1.28)  
Hysterectomy - radicality
 A 489 (90.72) 63 (90) 426 (90.83) 0.7491
 B 18 (3.34) 2 (2.86) 16 (3.41)  
 C 27 (5.01) 5 (7.14) 22 (4.69)  
 Not done 5 (0.93) 0 (0) 5 (1.07)  
PLND
 No 112 (20.78) 23 (32.86) 89 (18.98) 0.0076
 Yes 427 (79.22) 47 (67.14) 380 (81.02)  
PALND
 No 251 (46.57) 51 (72.86) 200 (42.64) <.0001
 Yes 288 (53.43) 19 (27.14) 269 (57.36)  
Adjuvant Chemotherapy
 No 455 (84.42) 66 (94.29) 389 (82.94) 0.0147
 Yes 84 (15.58) 4 (5.71) 80 (17.06)  
Adjuvant radiotherapy
 No 468 (86.83) 64 (91.43) 404 (86.14) 0.2224
 Yes 71 (13.17) 6 (8.57) 65 (13.86)  
  1. CCC clear cell carcinoma, NE neuroendocrine tumor, PLND pelvic lymph node dissection, PALND para-aortic lymph node dissection